News

Omada Health Shares Soar After IPO as GLP-1 Drugs Fuel Interest
Omada Health is making its public-market debut, propelled by Americans’ renewed focus on how weight affects physical health.
Digital health company Omada valued at $1.3 billion as shares jump in Nasdaq debut
(Reuters) -Shares of Omada Health rose 21% in their Nasdaq debut on Friday, valuing the virtual chronic care provider at ...
Omada Health: Helping Patients, Investors As Well?
Omada Health shows strong growth and innovation in chronic care but remains unprofitable with valuation, churn. See why OMDA ...
Devdiscourse3h
Surge in Synthetic Drug Threats and Drug Approvals Shake Health Sector
The EU faces a surge in new opioids and designer drugs, while the U.S. fast-tracks rare disease drugs. Brazil tackles bird ...
Omada valued at $1.3 billion as shares jump in Nasdaq debut
Virtual healthcare provider Omada secured a valuation of $1.28 billion after its shares jumped 21% in their Nasdaq debut on ...
Axios on MSN4d
Some unicorns have finally accepted reality, leading to IPOs
Venture capital's distribution blockade may be breaking down, at least a bit, thanks to some unicorns finally accepting that ...